Mycophenolate mofetil immunosuppression in high-risk renal transplant recipients

By Abouna G.M.   Al Arrayed A.S.   Farid E.   Awad C.K.   Sharqawi S.A.-D.   Tantawi M.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4077-4078

Elsevier

Access to resources Recommend Favorite

Renal function and safety of heart transplant recipients switched to mycophenolate mofetil and low-dose cyclosporine

By Baryalei M.   Zenker D.   Pieske B.   Tondo K.   Dalichau H.   Aleksic I.  

Transplantation Proceedings, Vol. 35, Iss. 4, 2003-06 ,pp. : 1539-1542

Elsevier

Access to resources Recommend Favorite

Randomized trial of tacrolimus in combination with mycophenolate mofetil versus cyclosporine with mycophenolate mofetil in cadaveric renal transplant recipients with delayed graft function

By Liu B.   Lin Z.B.   Ming C.S.   Zhang W.J.   Chen Z.S.   Sha B.   Zeng F.J.   Chen S.  

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 87-88

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil-induced hyperbilirubinemia in renal transplant recipients

By Chueh S.-C.   Huang C.-Y.   Lai M.-K.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1901-1902

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil, along with ATG and cyclosporine, significantly lowers the incidence of acute rejection episodes in renal transplant recipients

By Puig J.M.   Lloveras J.   Fernandez-Crespo P.   Mir M.   Inigo V.   Manresa J.M.   Masramon J.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2259-2260

Elsevier

Access to resources Recommend Favorite